Creative Planning
OSIR

Creative Planning’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Creative Planning’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-100
Closed -$1K – 4836
2015
Q4 		$1K Hold
100
– – ﹤0.01% 4367
2015
Q3 		$2K Buy
+100
New +$1.93K ﹤0.01% 4048
2015
Q2 		– Sell
-100
Closed -$2K – 4188
2015
Q1 		$2K Hold
100
– – ﹤0.01% 3983
2014
Q4 		$2K Buy
+100
New +$1.34K ﹤0.01% 3923

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return

Creative Planning's OSIR Position: Q1 2016 in Review

Creative Planning sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q1 2016, closing a stake of 100 shares — an estimated $1K sold.

Creative Planning first reported a position in OSIR in Q4 2014 and held it in 4 quarters. The position peaked at $2K in Q3 2015. 80 funds tracked by Wall St. Rank hold OSIR as of Q1 2016.

  • Creative Planning reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q1 2016 after selling out during the quarter.
  • Creative Planning sold 100 Osiris Therapeutics, Inc. Common Stock shares in Q1 2016, an estimated $1K.
  • Creative Planning first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2014 and held it in 4 quarters.
  • Creative Planning's Osiris Therapeutics, Inc. Common Stock position peaked at $2K in Q3 2015.
  • 80 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q1 2016.

Based on Creative Planning's 13F filing for Q1 2016, filed 8 Apr 2016.